English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues

MPS-Authors

Golda,  Gosia
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons241712

Grün,  Dominic
Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

10.1038_s41590-021-01013-0.pdf
(Publisher version), 19MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Friedrich, C., Taggenbrock, R. L. R. E., Doucet-Ladevèze, R., Golda, G., Moenius, R., Arampatzi, P., et al. (2021). Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues. Nature Immunology, 22, 1256-1267. doi:10.1038/s41590-021-01013-0.


Cite as: https://hdl.handle.net/21.11116/0000-000D-17EF-D
Abstract
Innate lymphoid cells (ILCs) participate in tissue homeostasis, inflammation, and early immunity against infection. It is unclear how ILCs acquire effector function and whether these mechanisms differ between organs. Through multiplexed single-cell mRNA sequencing, we identified cKit+CD127hiTCF-1hi early differentiation stages of T-bet+ ILC1s. These cells were present across different organs and had the potential to mature toward CD127intTCF-1int and CD127-TCF-1- ILC1s. Paralleling a gradual loss of TCF-1, differentiating ILC1s forfeited their expansion potential while increasing expression of effector molecules, reminiscent of T cell differentiation in secondary lymphoid organs. The transcription factor Hobit was induced in TCF-1hi ILC1s and was required for their effector differentiation. These findings reveal sequential mechanisms of ILC1 lineage commitment and effector differentiation that are conserved across tissues. Our analyses suggest that ILC1s emerge as TCF-1hi cells in the periphery and acquire a spectrum of organ-specific effector phenotypes through a uniform Hobit-dependent differentiation pathway driven by local cues.